Explore a comprehensive analysis of RNA expression in pediatric solid tumors to identify potential druggable targets in this 11-minute conference talk from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delve into Yvonne Vasquez's presentation, which focuses on difficult-to-treat pediatric solid tumors and the potential for targeted therapies. Gain insights into the latest advancements in clinical cancer genomics and their implications for accurate diagnosis and personalized treatment strategies. Learn how comparative RNA expression analysis can contribute to improving outcomes for young cancer patients by uncovering novel therapeutic targets.
Comparative Analysis of RNA Expression Identifies Druggable Targets in Pediatric Solid Tumors
Cancer Genomics Consortium via YouTube
Overview
Syllabus
Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors
Taught by
Cancer Genomics Consortium
Related Courses
-
Overcoming Challenges of Somatic RNA Variant Calling in Solid Tumors
-
Comprehensive Molecular Diagnostics and Advanced Gene Expression Analysis
-
A Female-Specific Chimeric RNA with Differential Expression in COVID Patients
-
Personalized Sequencing Assays for Cerebrospinal Fluid Liquid Biopsies in Children with Brain Tumors
-
SNP Array Analysis of Borderline Melanocytic Tumors
-
Utilizing Rapid Molecular Testing to Reduce Disparities in Pediatric Cancer in Sub-Saharan Africa
